Oncolytics Biotech: Funding, Investors & Team (Oct 2026)
Oncolytics Biotech focuses its research and development efforts on creating the cancer treatment REOLYSIN, which is derived from the reovirus. This virus has shown the ability to replicate in tumor cells with an activated Ras pathway, a protein that regulates cell growth and differentiation. The company's wholly owned subsidiaries are Oncolytics Biotech (Barbados) Inc. and Oncolytics Biotech (US) Inc. Founded in 1988, Oncolytics Biotech is headquartered in Calgary, Alberta, Canada.
Oncolytics Biotech has raised $20.0M across 1 funding round on record, the most recent an undisclosed round of $20.0M announced in Apr 2025.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Oncolytics Biotech Company Profile and Key Stats
Latest funding round on record: Apr 2025.
Oncolytics Biotech Funding Rounds
Oncolytics Biotech Founders and Leadership Team
No contact details are on record for this team yet.
Oncolytics Biotech Funding Compared to Other Biotechnology Startups
Oncolytics Biotech's latest round of $20.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Oncolytics Biotech in Biotechnology and Calgary
Companies Similar to Oncolytics Biotech
Tydra Labs is a biotechnology company that transforms crustacean shell waste into chitin and bio-products.
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
Oncolytics Biotech Funding FAQs
What does Oncolytics Biotech do?
Oncolytics Biotech focuses its research and development efforts on creating the cancer treatment REOLYSIN, which is derived from the reovirus. This virus has shown the ability to replicate in tumor cells with an activated Ras pathway, a protein that regulates cell growth and differentiation. The company's wholly owned subsidiaries are Oncolytics Biotech (Barbados) Inc. and Oncolytics Biotech (US) Inc. Founded in 1988, Oncolytics Biotech is headquartered in Calgary, Alberta, Canada.
How much funding has Oncolytics Biotech raised?
Oncolytics Biotech has raised $20.0M across 1 round on record. The most recent is an undisclosed round of $20.0M announced in Apr 2025.
When did Oncolytics Biotech last raise funding?
Oncolytics Biotech's most recent funding round on record is an undisclosed round of $20.0M, announced in Apr 2025.
Who founded Oncolytics Biotech?
FundedIQ lists Matt Coffey (Founder) at Oncolytics Biotech.
Where is Oncolytics Biotech headquartered?
Oncolytics Biotech is based in Calgary, Alberta, Canada.
How many employees does Oncolytics Biotech have?
Oncolytics Biotech is in the 11-50 employee band.
How does Oncolytics Biotech's funding compare to other Biotechnology startups?
Oncolytics Biotech's latest round of $20.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Oncolytics Biotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Oncolytics Biotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.